Sawtooth Solutions LLC Acquires New Position in Baxter International Inc (BAX)

Sawtooth Solutions LLC acquired a new position in Baxter International Inc (NYSE:BAX) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,693 shares of the medical instruments supplier’s stock, valued at approximately $239,000.

Several other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC raised its stake in shares of Baxter International by 4.4% in the fourth quarter. Geode Capital Management LLC now owns 5,812,690 shares of the medical instruments supplier’s stock worth $375,011,000 after purchasing an additional 247,337 shares during the last quarter. Two Sigma Advisers LP increased its position in shares of Baxter International by 6.8% during the fourth quarter. Two Sigma Advisers LP now owns 3,695,958 shares of the medical instruments supplier’s stock valued at $238,907,000 after acquiring an additional 236,000 shares during the last quarter. TIAA CREF Investment Management LLC increased its position in shares of Baxter International by 0.5% during the fourth quarter. TIAA CREF Investment Management LLC now owns 3,654,214 shares of the medical instruments supplier’s stock valued at $236,208,000 after acquiring an additional 19,093 shares during the last quarter. Old Mutual Global Investors UK Ltd. increased its position in shares of Baxter International by 18.1% during the fourth quarter. Old Mutual Global Investors UK Ltd. now owns 3,098,384 shares of the medical instruments supplier’s stock valued at $200,279,000 after acquiring an additional 474,520 shares during the last quarter. Finally, Winslow Capital Management LLC purchased a new stake in shares of Baxter International during the fourth quarter valued at approximately $178,651,000. 85.54% of the stock is owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

In other Baxter International news, Director Carole J. Shapazian sold 4,990 shares of the firm’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $66.05, for a total value of $329,589.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Giuseppe Accogli sold 28,641 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $67.00, for a total value of $1,918,947.00. The disclosure for this sale can be found here. Company insiders own 0.05% of the company’s stock.

Shares of Baxter International stock opened at $64.29 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.57 and a quick ratio of 2.05. Baxter International Inc has a 52-week low of $51.39 and a 52-week high of $72.58. The stock has a market capitalization of $34,725.54, a price-to-earnings ratio of 49.84, a price-to-earnings-growth ratio of 1.85 and a beta of 0.82.

Baxter International (NYSE:BAX) last released its earnings results on Thursday, February 1st. The medical instruments supplier reported $0.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.05. Baxter International had a return on equity of 15.11% and a net margin of 6.79%. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.77 billion. During the same period last year, the business posted $0.57 earnings per share. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. equities analysts predict that Baxter International Inc will post 2.78 EPS for the current fiscal year.

Baxter International announced that its board has initiated a share buyback program on Tuesday, February 20th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the medical instruments supplier to purchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Friday, March 2nd will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Thursday, March 1st. Baxter International’s dividend payout ratio is currently 49.61%.

A number of analysts recently commented on BAX shares. Zacks Investment Research downgraded Baxter International from a “buy” rating to a “hold” rating in a research report on Tuesday, December 26th. Bank of America raised Baxter International from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 2nd. Evercore ISI started coverage on Baxter International in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $71.00 price target for the company. Royal Bank of Canada reaffirmed a “hold” rating and set a $72.00 price target on shares of Baxter International in a research report on Friday, February 2nd. Finally, ValuEngine downgraded Baxter International from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Eight investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the stock. Baxter International currently has an average rating of “Buy” and a consensus target price of $71.27.

ILLEGAL ACTIVITY WARNING: “Sawtooth Solutions LLC Acquires New Position in Baxter International Inc (BAX)” was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3299097/sawtooth-solutions-llc-acquires-new-position-in-baxter-international-inc-bax.html.

About Baxter International

Baxter International Inc, through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products.

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Bankcoin 24 Hour Volume Hits $0.00
Bankcoin 24 Hour Volume Hits $0.00
Elementrem  Trading 1.4% Lower  This Week
Elementrem Trading 1.4% Lower This Week
Fastcoin Trading 1% Higher  Over Last Week
Fastcoin Trading 1% Higher Over Last Week
Kadant  Expected to Post Quarterly Sales of $145.40 Million
Kadant Expected to Post Quarterly Sales of $145.40 Million
Zacks: Brokerages Expect GameStop  to Post $0.40 EPS
Zacks: Brokerages Expect GameStop to Post $0.40 EPS
$0.83 Earnings Per Share Expected for Consol Energy  This Quarter
$0.83 Earnings Per Share Expected for Consol Energy This Quarter


© 2006-2018 Ticker Report. Google+.